The current expansion of global drug-based research at an advancing rate is fueling an increase in the global demand of test subjects. The conventional pre-clinical trials method is fraught to face several challenges such as ethical concerns, data inaccuracy, cost inefficiency and time. Organ-on-chips (OOCs) are an upcoming class of therapeutic testing models that have garnered significant...

Organ-on-chips (OOCs) are an upcoming class of therapeutic testing models that have garnered significant attention of pharmaceutical companies, and academic / research institutions across the globe. More than 70 organ-on-a-chip technologies and models have been launched / approved or are currently under development; notably, the market landscape features the presence of both established...

More than 600 patents related to organ-on-a-chip have been filed / granted by industry and non-industry stakeholders, indicating a growing intellectual capital in the domain. More than 600 patent instances, wherein companies as well as academic institutes working in this domain have filed their innovative technologies. Out of all the registered patents, majority (more than 60%) patents have...

Organ-on-chips (OOCs) are an upcoming class of therapeutic testing models that have garnered significant attention of pharmaceutical companies, and academic / research institutions across the globe. The global Organs-on-chips market is expected to grow from USD 100 million in 2025 to USD 129 million in 2026 and USD 944 million by 2035, at CAGR of 24.8% during the forecast period. More than 70...